Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine
2025 · Biomedicine & Pharmacotherapy · 4 citations
https://doi.org/10.1016/j.biopha.2025.117955
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
65
Citations
4
h-index
2
i10-index
Cheng Wang is an academic researcher from Shandong Provincial Hospital. The author has contributed to research in topics: Hippo pathway signaling and YAP/TAZ & Hepatocellular Carcinoma Treatment and Prognosis & DNA Repair Mechanisms. The author has an h-index of 4, co-authored 17 publications.
ORCID: 0000-0002-4392-5113https://doi.org/10.1016/j.biopha.2025.117955
https://doi.org/10.1371/journal.pone.0131546.t003
https://doi.org/10.6084/m9.figshare.5035604
Click to start Chat